Active Biotech AB Price Analysis - ACTI SWEDEN Market Size, Market Share and Demand Forecast

Wright Reports > Price Analysis Report > A > Active Biotech AB

Active Biotech AB - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Active Biotech AB. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Active Biotech AB. The Group's principal activity is to develop pharmaceuticals and vaccines for infectious and auto immune as well as inflammatory disease. The Group portfolio includes innovative substances that modulate the human immune system. It also develops products designed to treat multiple sclerosis, as well as lung, renal and pancreatic cancer.The group has a patent portfolio that comprises 23 strategic patent families in key projects.

Not the Report you are looking for? Click here for more browsing options.

add Premium Analyses Reports:
Purchase Reports:			(Combined total)
ALL Basic Reports on this Company	$39.95	+ Analyses Reports	$64.95
Single Price Analysis Report	$24.95
or SUBSCRIBE for full access** to over 180,000 company reports:
Monthly Basic Subscription	$59.99	+ Analyses Reports	$89.99
Annual Basic Subscription	$600/yr	+ Analyses Reports	$900/yr

* If a currency is not selected, the report will be delivered in the local currency of the company
** Full access limits users to 500 reports per month

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report

HOME | ABOUT US | FEEDBACK | HELP | CONTENT MAP
Terms and Conditions